E-Therapeutics PLC
- Biotech or pharma, therapeutic R&D
e-therapeutics is at the intersection of computational biology and genetic medicine. We have built an integrated computational platform leveraging AI, proprietary network analysis and curated datasets for novel/differentiated target identification and predictive oligo design. We deliver novel siRNA therapies leveraging our proprietary GalOmic chemistries and our lead programs in IND-enabling studies are expected to enter the clinic in 2H2025 (MASH) and mid-2026 (bleeding disorders).
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}